Progress Report on Access to Hepatitis C Treatment: Focus on Overcoming Barriers in Low and Middle Income Countries

This report updates the first edition, published in 2016, and reviews the progress countries have made in expanding access to life-saving direct-acting antivirals (DAAs). The report reviews the main challenges countries face and describes recent developments in relation to five key factors that determine access to DAA medicines: affordability, quality assurance, regulatory approval, government commitment and financing.